Agile Therapeutics Inc. (AGRX) reported positive results from its phase III trial of its once-weekly contraceptive patch Twirla after the close Tuesday. The PEARL-index score of Twirla was 4.80 in subjects 35 years of age and under. The Pearl Index is the number of failures that will occur among 100 women using a contraceptive method for a year.
from RTT - Before the Bell http://ift.tt/2iTc6JT
via IFTTT
No comments:
Post a Comment